InvestorsHub Logo
Followers 2
Posts 251
Boards Moderated 0
Alias Born 05/29/2019

Re: None

Tuesday, 10/20/2020 9:58:19 PM

Tuesday, October 20, 2020 9:58:19 PM

Post# of 232969
Oh, ya. And more COVID:

Today a peer review publication in the journal Clinical Infectious Diseases: "Clinical Characteristics and Outcomes of COVID-19 Patients Receiving Compassionate Use Leronlimab". Commenting on this article, Dr. XYZ, an infections disease specialist at ZYX Hospital stated: "Leronlimab, as a treatment for Critical COVID patients, appears to be saving lives. I am pleased to here that the clinical trials are well underway and the DSMC recommendations to Cytodyn on their interim analysis of the Leronlimab data was positive".

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CYDY News